Literature DB >> 21843775

Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model.

Samuel Valable1, Edwige Petit, Simon Roussel, Léna Marteau, Jérôme Toutain, Didier Divoux, Franck Sobrio, Jérôme Delamare, Louisa Barré, Myriam Bernaudin.   

Abstract

INTRODUCTION: No direct proof has been brought to light in a link between hypoxic changes in glioma models and the effects of antiangiogenic treatments. Here, we assessed the sensitivity of the detection of hypoxia through the use of (18)F-fluoromisonidazole positron emission tomography ([(18)F]-FMISO PET) in response to the evolution of the tumor and its vasculature.
METHODS: Orthotopic glioma tumors were induced in rats after implantation of C6 or 9L cells. Sunitinib was administered from day (D) 17 to D24. At D17 and D24, multiparametric magnetic resonance imaging was performed to characterize tumor growth and vasculature. Hypoxia was assessed by [(18)F]-FMISO PET.
RESULTS: We showed that brain hypoxic volumes are related to glioma volume and its vasculature and that an antiangiogenic treatment, leading to an increase in cerebral blood volume and a decrease in vessel permeability, is accompanied by a decrease in the degree of hypoxia.
CONCLUSIONS: We propose that [(18)F]-FMISO PET and multiparametric magnetic resonance imaging are pertinent complementary tools in the evaluation of the effects of an antiangiogenic treatment in glioma.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21843775     DOI: 10.1016/j.nucmedbio.2011.01.010

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  24 in total

1.  Response of HT29 colorectal xenograft model to cediranib assessed with 18 F-fluoromisonidazole positron emission tomography, dynamic contrast-enhanced and diffusion-weighted MRI.

Authors:  Louisa Bokacheva; Khushali Kotedia; Megan Reese; Sally-Ann Ricketts; Jane Halliday; Carl H Le; Jason A Koutcher; Sean Carlin
Journal:  NMR Biomed       Date:  2012-07-08       Impact factor: 4.044

2.  Monitoring photodynamic therapy with photoacoustic microscopy.

Authors:  Peng Shao; David W Chapman; Ronald B Moore; Roger J Zemp
Journal:  J Biomed Opt       Date:  2015-10       Impact factor: 3.170

3.  Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [18F]Fluoromisonidazole ([18F]FMISO) Kinetic Analysis and Invasive Oxygen Measurements.

Authors:  Olivia J Kelada; Sara Rockwell; Ming-Qiang Zheng; Yiyun Huang; Yanfeng Liu; Carmen J Booth; Roy H Decker; Uwe Oelfke; Richard E Carson; David J Carlson
Journal:  Mol Imaging Biol       Date:  2017-12       Impact factor: 3.488

4.  [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis.

Authors:  Lien Bekaert; Samuel Valable; Emmanuèle Lechapt-Zalcman; Keven Ponte; Solène Collet; Jean-Marc Constans; Guénaëlle Levallet; Karim Bordji; Edwige Petit; Pierre Branger; Evelyne Emery; Alain Manrique; Louisa Barré; Myriam Bernaudin; Jean-Sébastien Guillamo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03-18       Impact factor: 9.236

5.  A comparison of PET imaging agents for the assessment of therapy efficacy in a rodent model of glioma.

Authors:  Shehzahdi S Moonshi; Romain Bejot; Zeenat Atcha; Vimalan Vijayaragavan; Kishore K Bhakoo; Julian L Goggi
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-09-19

6.  Imaging of brain oxygenation with magnetic resonance imaging: A validation with positron emission tomography in the healthy and tumoural brain.

Authors:  Samuel Valable; Aurélien Corroyer-Dulmont; Ararat Chakhoyan; Lucile Durand; Jérôme Toutain; Didier Divoux; Louisa Barré; Eric T MacKenzie; Edwige Petit; Myriam Bernaudin; Omar Touzani; Emmanuel L Barbier
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

7.  18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy.

Authors:  Milan Grkovski; Sally-Ann Emmas; Sean D Carlin
Journal:  J Nucl Med       Date:  2017-03-30       Impact factor: 10.057

8.  Carbogen-induced increases in tumor oxygenation depend on the vascular status of the tumor: A multiparametric MRI study in two rat glioblastoma models.

Authors:  Ararat Chakhoyan; Aurélien Corroyer-Dulmont; Marine M Leblond; Aurélie Gérault; Jérôme Toutain; Laurent Chazaviel; Didier Divoux; Edwige Petit; Eric T MacKenzie; François Kauffmann; Nicolas Delcroix; Myriam Bernaudin; Omar Touzani; Samuel Valable
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

9.  ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI.

Authors:  Elizabeth R Gerstner; Zheng Zhang; James R Fink; Mark Muzi; Lucy Hanna; Erin Greco; Melissa Prah; Kathleen M Schmainda; Akiva Mintz; Lale Kostakoglu; Edward A Eikman; Benjamin M Ellingson; Eva-Maria Ratai; A Gregory Sorensen; Daniel P Barboriak; David A Mankoff
Journal:  Clin Cancer Res       Date:  2016-05-16       Impact factor: 12.531

Review 10.  The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities.

Authors:  Joseph C Walsh; Artem Lebedev; Edward Aten; Kathleen Madsen; Liane Marciano; Hartmuth C Kolb
Journal:  Antioxid Redox Signal       Date:  2014-05-09       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.